Martin Hessing

Martin Hessing discloses dealings in ImmunoPrecise Antibodies Ltd. to SEDI. In total, 5 filings cover trades dated from 19 September 2019 to 28 October 2019.

Every open-market trade on record is a purchase: 5 purchases worth €7,373, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

In size, the median ticket on the buying side is €1,709. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 28 October 2019, reports an open-market purchase of €1,864 in ImmunoPrecise Antibodies Ltd. Half of the filings or more reach the SEDI feed on the day of the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.